葛兰素史克(GSK)在夜间交易中大涨5.34%,引发投资者广泛关注。这主要是由于其公布的利好业绩和未来发展前景所致。
在业绩方面,葛兰素史克2024年第四季度每股调整后收益为0.59美元,高于分析师预期的0.43美元,同比下降17.13%。季度销售额达104.04亿美元,也高于预期的95.79亿美元,同比增长3.37%。公司业绩出色超出市场预期,反映了其在各业务板块的良好表现。
展望2025财年,葛兰素史克预计其营业额将以固定汇率计增长3%至5%,核心营业利润和核心每股收益也将分别增长6%至8%。该公司预计专业药品营业额将实现低双位数增长,疫苗营业额将小幅下滑,而普通药品营业额将保持基本稳定。整体来说,公司发展前景乐观,未来增长可期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.